Associated Papers
Precision screening facilitates clinical classification of BRCA2-PALB2 binding variants with benign and pathogenic functional effects.
Bose M et al.
The Journal of Clinical Investigation, 2025
40232841 (PubMed )
Supplement: jci-135-181879-s033.xlsx › Supplementary_Table_4
Mismatch repair protein MLH1 suppresses replicative stress in BRCA2-deficient breast tumors.
Sengodan SK et al.
The Journal of Clinical Investigation, 2024
38271119 (PubMed )
Supplement: jci-134-173718-s071.xlsx › Fig_S8K
Understanding and predicting the functional consequences of missense mutations in BRCA1 and BRCA2.
Aljarf R et al.
Scientific Reports, 2022
35729312 (PubMed )
Supplement: 41598_2022_13508_MOESM2_ESM.xlsx › Sheet1
Comprehensive genomic characterization of breast tumors with BRCA1 and BRCA2 mutations.
Lal A et al.
Bmc Medical Genomics, 2019
31182087 (PubMed )
Supplement: 12920_2019_545_MOESM10_ESM.xlsx › methylation
Select a paper to view details